{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:32:05Z","timestamp":1761586325073,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660269","81860300"],"award-info":[{"award-number":["81660269","81860300"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108292","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T21:29:10Z","timestamp":1635456550000},"page":"108292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["Characterizing the BCR repertoire during lymphocyte reduction and recovery mediated by cyclophosphamide and granulocyte-macrophage colony-stimulating factor"],"prefix":"10.1016","volume":"101","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinsheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108292_b0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevImmunol.v28.i2.20","article-title":"Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide","volume":"28","author":"Brode","year":"2008","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.108292_b0010","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-10-0100","article-title":"Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors","volume":"70","author":"Dai","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2021.108292_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1476-4598-13-158","article-title":"Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2","volume":"13","author":"Doloff","year":"2014","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.intimp.2021.108292_b0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.intimp.2021.108292_b0025","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2018-05-848671","article-title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","volume":"132","author":"Fajgenbaum","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.108292_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-016-4028-0","article-title":"Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review","volume":"161","author":"Fernandes","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2021.108292_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2051-1426-2-11","article-title":"Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma","volume":"2","author":"Kaufman","year":"2014","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.intimp.2021.108292_b0040","first-page":"71","article-title":"Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia","volume":"3","author":"Kil","year":"2013","journal-title":"Am. J. Blood Res."},{"key":"10.1016\/j.intimp.2021.108292_b0045","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","article-title":"Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1\u03b2","volume":"50","author":"Komuczki","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.108292_b0050","first-page":"21","article-title":"The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion","volume":"22","author":"Liu","year":"2017","journal-title":"J. B.U.ON.: Official J. Balkan Union of Oncology"},{"key":"10.1016\/j.intimp.2021.108292_b0055","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00262-020-02542-7","article-title":"Combined blockade of TGf-\u03b21 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment","volume":"69","author":"Liu","year":"2020","journal-title":"Cancer Immunology, Immunotherapy : CII"},{"key":"10.1016\/j.intimp.2021.108292_b0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10565-018-9426-0","article-title":"History, applications, and challenges of immune repertoire research","volume":"34","author":"Liu","year":"2018","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2021.108292_b0065","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","article-title":"Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update","volume":"10","author":"Lotfi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108292_b0070","doi-asserted-by":"crossref","unstructured":"H. Mehta, M. Malandra, S. Corey, G-CSF and GM-CSF in neutropenia, J. Immunology (Baltimore, Md. : 1950) 195 (2015) 1341-1349.","DOI":"10.4049\/jimmunol.1500861"},{"key":"10.1016\/j.intimp.2021.108292_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030611","article-title":"The role of granulocyte-macrophage colony-stimulating factor in murine models of multiple sclerosis","volume":"9","author":"Monaghan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2021.108292_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12667","article-title":"Human adaptive immune receptor repertoire analysis-Past, present, and future","volume":"284","author":"Nielsen","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2021.108292_b0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pop.2016.07.005","article-title":"Novel developments in leukopenia and pancytopenia","volume":"43","author":"Onuoha","year":"2016","journal-title":"Prim. Care"},{"key":"10.1016\/j.intimp.2021.108292_b0090","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.2019004118","article-title":"Hepatosplenic T-cell lymphoma: a rare but challenging entity","volume":"136","author":"Pro","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.108292_b0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autrev.2016.12.005","article-title":"Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials","volume":"16","author":"Qiu","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2021.108292_b0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-021-01374-y","article-title":"GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer\/T cell lymphoma","volume":"20","author":"Rong","year":"2021","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.intimp.2021.108292_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2015.08.011","article-title":"Cytotoxic activity of T lymphocytes is induced upon stimulation with IL-3 plus GM-CSF in animal leukemia model","author":"Singha","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.intimp.2021.108292_b0110","first-page":"E458","article-title":"VH replacement in primary immunoglobulin repertoire diversification","volume":"112","author":"Sun","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2021.108292_b0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916934.2014.914174","article-title":"Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease","volume":"47","author":"Venhoff","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2021.108292_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661052","article-title":"SARS-CoV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108292_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1479-5876-9-215","article-title":"Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease","volume":"9","author":"Xuan","year":"2011","journal-title":"J. Translational Med."},{"key":"10.1016\/j.intimp.2021.108292_b0130","first-page":"243","article-title":"Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure","volume":"43","author":"Yan","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2021.108292_b0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/08923973.2020.1728309","article-title":"The effects of CTX damage or inhibition of bone marrow hematopoiesis and GM-CSF stimulation of bone marrow hematopoiesis on the peripheral blood TCR\u03b2 CDR3 repertoire of BALB\/c mice","volume":"42","author":"Yang","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2021.108292_b0140","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1634\/stemcells.2006-0807","article-title":"Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I\/II clinical trial","volume":"25","author":"Yoon","year":"2007","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.intimp.2021.108292_b0145","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3389\/fimmu.2019.02679","article-title":"The pleiotropic effects of the GM-CSF rheostat on myeloid cell differentiation and function: more than a numbers game","volume":"10","author":"Zhan","year":"2019","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:28:12Z","timestamp":1761586092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921009280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"alternative-id":["S1567576921009280"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108292","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the BCR repertoire during lymphocyte reduction and recovery mediated by cyclophosphamide and granulocyte-macrophage colony-stimulating factor","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108292"}}